Covered recipient · General Payments record
SHARI E SAMSON
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2024
$2,452.31
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $487.90 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | $142.90 | 2 |
| ABIOMED | $124.13 | 1 |
| Heron Therapeutics, Inc. | $122.10 | 1 |
| Merck Sharp & Dohme Corporation | $69.68 | 4 |
| Pacira Pharmaceuticals Incorporated | $15.27 | 1 |
| CHIESI USA, INC. | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $124.13 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142220904 | CMS |
| Chiesi USA, Inc. | $13.82 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151819826 | CMS |
| EAGLE PHARMACEUTICALS, INC. | $18.11 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120209347 | CMS |
| EAGLE PHARMACEUTICALS, INC. | $124.79 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120209897 | CMS |
| Heron Therapeutics, Inc. | $122.10 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147249587 | CMS |
| Merck Sharp & Dohme LLC | $18.27 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141894437 | CMS |
| Merck Sharp & Dohme LLC | $15.66 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141894435 | CMS |
| Merck Sharp & Dohme LLC | $17.31 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141772100 | CMS |
| Merck Sharp & Dohme LLC | $18.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141772102 | CMS |
| Pacira Pharmaceuticals Incorporated | $15.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151258868 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.